Quartz

Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down today

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market — which is projected to hit $105 billion by 2030, according to Morgan Stanley (MS) analysts.Read more...

Mar 13, 2025 - 17:53
 0
Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down today

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market — which is projected to hit $105 billion by 2030, according to Morgan Stanley (MS) analysts.

Read more...

Read More

Tags:

Previous Article

There's an upside for the housing market in all this economic uncertainty — for now

Next Article

Halozyme Stock Offers Early Buy Point As Company Hits $1 Billion In Revenue

Related Posts

McDonald's earnings miss due to E. Coli outbreak and a decline in consumer spending

McDonald's earnings miss due to E. Coli outbreak and a ...

Feb 10, 2025  0

Bitcoin, Ether, Solana, Cardano and more cryptocurrencies to watch this week

Bitcoin, Ether, Solana, Cardano and more cryptocurrenci...

Mar 3, 2025  0

Target's price hikes, Walmart's China strategy, and Starbucks' tough love: Retail news roundup

Target's price hikes, Walmart's China strategy, and Sta...

Mar 7, 2025  0